These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 15604962)
1. Visualization of the gall bladder on F-18 FDOPA PET imaging: a potential pitfall. Balan KK Clin Nucl Med; 2005 Jan; 30(1):23-4. PubMed ID: 15604962 [No Abstract] [Full Text] [Related]
2. Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT: focus on pheochromocytomas. Moreau A; Giraudet AL; Kryza D; Borson-Chazot F; Bournaud C; Mognetti T; Lifante JC; Combemale P; Giammarile F; Houzard C Nucl Med Commun; 2017 Sep; 38(9):771-779. PubMed ID: 28704339 [TBL] [Abstract][Full Text] [Related]
3. False-positive findings on 6-[18F]fluor-l-3,4-dihydroxyphenylalanine PET ( Berends AMA; Kerstens MN; Bolt JW; Links TP; Korpershoek E; de Krijger RR; Walenkamp AME; Noordzij W; van Etten B; Kats-Ugurlu G; Brouwers AH; van der Horst-Schrivers ANA Eur J Endocrinol; 2018 Aug; 179(2):125-133. PubMed ID: 29875288 [TBL] [Abstract][Full Text] [Related]
4. The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma. Timmers HJ; Hadi M; Carrasquillo JA; Chen CC; Martiniova L; Whatley M; Ling A; Eisenhofer G; Adams KT; Pacak K J Nucl Med; 2007 Oct; 48(10):1599-606. PubMed ID: 17873132 [TBL] [Abstract][Full Text] [Related]
5. 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression. Fottner C; Helisch A; Anlauf M; Rossmann H; Musholt TJ; Kreft A; Schadmand-Fischer S; Bartenstein P; Lackner KJ; Klöppel G; Schreckenberger M; Weber MM J Clin Endocrinol Metab; 2010 Jun; 95(6):2800-10. PubMed ID: 20371665 [TBL] [Abstract][Full Text] [Related]
6. The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas. Taïeb D; Tessonnier L; Sebag F; Niccoli-Sire P; Morange I; Colavolpe C; De Micco C; Barlier A; Palazzo FF; Henry JF; Mundler O Clin Endocrinol (Oxf); 2008 Oct; 69(4):580-6. PubMed ID: 18394015 [TBL] [Abstract][Full Text] [Related]
7. Simulation-based partial volume correction for dopaminergic PET imaging: Impact of segmentation accuracy. Rong Y; Vernaleken I; Winz OH; Goedicke A; Mottaghy FM; Kops ER Z Med Phys; 2015 Sep; 25(3):230-42. PubMed ID: 25172832 [TBL] [Abstract][Full Text] [Related]
8. Decoupled association between (18)F-FDG and (18)F-FDOPA uptake in a carcinoid of the thymus. Chiaravalloti A; Schillaci O Rev Esp Med Nucl Imagen Mol; 2016; 35(2):139-40. PubMed ID: 26260888 [No Abstract] [Full Text] [Related]
9. Effect of Carbidopa on 18F-FDOPA Uptake in Insulinoma: From Cell Culture to Small-Animal PET Imaging. Detour J; Pierre A; Boisson F; Kreutter G; Lavaux T; Namer IJ; Kessler L; Brasse D; Marchand P; Imperiale A J Nucl Med; 2017 Jan; 58(1):36-41. PubMed ID: 27609787 [TBL] [Abstract][Full Text] [Related]
10. 18F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors. Minn H; Kemppainen J; Kauhanen S; Forsback S; Seppänen M PET Clin; 2014 Jan; 9(1):27-36. PubMed ID: 25029931 [TBL] [Abstract][Full Text] [Related]
11. 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas. Imani F; Agopian VG; Auerbach MS; Walter MA; Imani F; Benz MR; Dumont RA; Lai CK; Czernin JG; Yeh MW J Nucl Med; 2009 Apr; 50(4):513-9. PubMed ID: 19289420 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma. Liu YL; Lu MY; Chang HH; Lu CC; Lin DT; Jou ST; Yang YL; Lee YL; Huang SF; Jeng YM; Lee H; Miser JS; Lin KH; Liao YF; Hsu WM; Tzen KY Oncotarget; 2016 Apr; 7(14):18774-86. PubMed ID: 26959748 [TBL] [Abstract][Full Text] [Related]